Fit-for-purpose PK assay for a novel bispecific nanobody

Discover how Syngene developed a fit-for-purpose PK assay for a novel bispecific nanobody, achieving a 1.00 to 1000 ng/mL dynamic range and a low 1% repeat rate to support clinical dose selection.